Higher risk of liver cancer seen in women with intrahepatic cholestasis of pregnancy
the ONA take:
Researchers at the Sahlgrenska Academy found that women with intrahepatic cholestasis of pregnancy (ICP) are at increased risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life.
Using the Swedish Medical Birth Register and the Swedish Patient Register, the investigators identified 11,388 women with ICP and 113,893 women without ICP who gave birth between 1973 and 2009.
Study findings showed risk for cancer in the biliary tree and risk for liver cancer were 2.5 times higher and 3.5 times higher, respectively, compared with matched controls. In addition, patients with ICP were found to be at higher risk for thyroid disease, diabetes, psoriasis, and Crohn’s disease. Women with both ICP and preeclampsia during pregnancy had a slightly higher risk for cardiovascular disease.
The investigators recommend follow-up of serum liver tests 6 to 12 weeks after delivery for all women with ICP, and further evaluation by a hepatologist if serum liver tests results are elevated.
Women with intrahepatic cholestasis of pregnancy (ICP) are at increased risk of hepatobiliary cancer.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
- Pediatric Patients, Parents Overreport Adherence to ALL Medication Regimen
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|